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Background: Post-malaria neurological syndrome
(PMNS) is defined as the acute onset of neurological
or neuropsychiatric syndrome in a patient who had
recently recovered from malaria and have negative
blood film at the time of onset of neurological
symptoms. This, therefore, distinguishes it from
cerebral malaria, which occurs during the period of
parasitaemia. The time from eradication of systemic
parasitaemia to the development of this syndrome
can be up to nine weeks1. The prevalence of PMNS
in patients with malaria is 0.12% and is 300 times
more common in patients with severe malaria in
comparison to uncomplicated malaria1. The reported
clinical features include generalised convulsions,
acute confusional state, psychosis, tremors, cerebellar
ataxia, motor aphasia, and generalised myoclonus2,3.
Most of these patients made complete recovery
without specific treatment. Almost all reported
PMNS cases are associated with episode of P.
falciparum malaria. We report a case of bilateral
facial palsy developing on 14th day of afebrile period
after successful treatment of vivax malaria and had
complete recovery in next four weeks.
Case report: A 55 year-old male (RG) was admitted
in the hospital with complaints of fever, nausea and
vomiting for last four days. Fever was associated with
chills and rigors, and occurring on alternate days.
Patient was conscious, oriented and there was no
icterus, pallor, lymphadenopathy or cynosis. Skin
was of normal texture and other systems including
cardiovascular, respiratory, nervous system were
normal. Peripheral blood film (PBF) for malarial
parasite was positive for P. vivax (Fig. 1), which was
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also confirmed by rapid diagnostic test (pLDH
antigen for vivax was positive and pLDH as well as
HRP2 for falciparum was negative). Parasite density
was 15000/mm3. Other relevant investigations were
within normal limits. Patient was treated with oral
chloroquine in the dose of 600 mg followed by 300
mg after six hours and then 12 hourly so as to make
a total of 1500 mg. The patient became afebrile after
two days and PBF done at the time of discharge was
showing no evidence of parasites. On Day 14 of
afebrile period, he was admitted again in the hospital
with complaints of drooling of saliva from angle of
mouth, alteration in speech and taste and inability to
close his eyes during sleep. He was fully conscious
and well-oriented. The detailed neurological
examination revealed bilateral infra-nuclear facial
palsy, absence of wrinkles of forehead, loss of taste
sensation on anterior 2/3 of tongue and absent corneal
reflex. All relevant investigations were done to rule
out other locally prevalent infectious diseases as well
as metabolic and neurological disorders. No specific
treatment was given and the patient made complete
recovery within four weeks.
PMNS occurs up to nine weeks after complete
recovery from P. falciparum malaria1. Only two
case reports are available in literature about PMNS
after vivax malaria in which one case was of acute
inflammatory demyelinating polyneuropathy4 and
another case was of acute disseminated encephalo-
myelitis like picture5. This case can also be
presumed to be a definite case of vivax malaria as
diagnosed by PBF examination which showed only
vivax infection and rapid diagnostic test showing
positive evidence of pLDH antigen of P. vivax and
was negative for pLDH as well as HRP2 antigen of
P. falciparum. Even if we presume that P.
falciparum may not be seen in PBF in a patient of
mixed infection, it could have been picked up by
the presence of HRP-2 antigen in rapid diagnostic
test (RDT). The presentation with neurological
deficit after two weeks of complete recovery from
confirmed attack of malaria is a strong evidence of
the diagnosis of PMNS. However, we had tried to
rule out other possibilities by appropriate tests.
The etiology of PMNS remains unclear and a wide
range of neurological manifestations have been
reported. In cerebral malaria, sequestration of
parasitised red blood cell within cerebral vessels
can result in local ischemic damage6 but this
mechanism cannot be implicated in PMNS, where
by definition no parasitised red blood cells are
present at the time of neurological involvement.
There are no reports in literature about bilateral
facial palsy in association with the use of
chloroquine. Incidentally, P. vivax infection in this
region had also been associated with severe
manifestations7. The report of PMNS from the
same region may be of great significance in the
term of changing behaviour of organism in this
part of world. These two observations (severe
vivax malaria and PMNS after vivax infection)
from the same geographical region is a matter of
great concern.
References
1. Nguyen TH, Day NP, Ly VC, Waller D, Nguyen HP,
Bethell DB, Tran TH, White NJ. Post-malaria neurological
syndrome. Lancet 1996; 348(9032): 917–21.
2. de Silva HJ, Gamage R, Herath HK, Abeysekera DT,
Peiris JB. A delayed onset cerebellar syndrome
complicating falciparum malaria. Ceylon Med J 1986;
31(3): 147–50.
3. Schnorf  H, Diserens K, Schnyder H, Chofflon M, Loutan
L, Chaves V, Landis T. Corticosteroid-responsive post-
malaria encephalopathy characterized by motor aphasia,
myoclonus, and postural tremor. Arch Neurol 1998; 55(3):
417–20.
4. Chakravarty A, Ghosh B, Bhattacharyya R, Sengupta S,
Mukherjee S. Acute inflammatory demyelinating
polyneuropathy following Plasmodium vivax malaria.
Neurol India 2004; 52(1): 130–1.
5. Koibuchi T, Nakamura T, Miura T, Endo T, Nakamura H,KOCHAR et al:  PMNS AFTER P. VIVAX INFECTION 229
Takahashi T, Kim HS, Wataya Y, Washizaki K, Yoshikawa
K, Iwamoto A. Acute disseminated encephalomyelitis
following Plasmodium vivax malaria. J Infect Chemother
2003; 9(3): 254–6.
6. Newton CRJC, Warrell DA. Neurological manifesta-
Corresponding author: Dr. D.K. Kochar, C-54,  Sadul Ganj, Bikaner–334 003, India.
E-mail: drdkkochar@yahoo.com; drdkkochar@inditimes.com
Received: 9 January 2007 Accepted in revised form:  2 March 2007
tions of falciparum malaria. Ann Neurol 1998; 43: 695–
702.
7. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV,
Das A. Plasmodium vivax malaria. Emerg Infect Dis 2005;
11(1): 132–4.